
Max Healthcare Institute's Proceedings Adjourned by NCLT Cuttack Bench until August 4, 2026
The legal proceedings before the National Company Law Tribunal (NCLT), Cuttack Bench, involving Kalinga Hospital Ltd. and Max Healthcare Institute Limited have been adjourned for further hearing.This update relates to petitions, including an interlocutory petition, filed by BRS Capital Two Pte. Limited against Kalinga Hospital Ltd. (KHL). KHL is a subsidiary of Max Healthcare Institute Limited, and the proceedings also involve the company given its acquisition of a majority equity stake in KHL from another shareholder.
The case was listed before the Tribunal on July 23, 2026. The outcome of the listing confirmed that the NCLT Cuttack Bench has adjourned the matter, setting aside the next hearing date for August 4, 2026.
The status and developments regarding this ongoing litigation are detailed below:
| S. No. | Particulars | Details |
|---|---|---|
| The details of any change in the status and / or any development in relation to such proceedings | The Hon'ble National Company Law Tribunal, Cuttack Bench has adjourned the matter to August 4, 2026 for further hearing. |
MAXHEALTH Stock Price Movement
Shares of Max Healthcare Institute Limited are shedding ground during the day, dipping 0.50% and trading at ₹1078.8 as of 12:21 PM. Trading activity stands at 456,261 shares as the stock bounces between a daily low of ₹1068.8 and a high marking at ₹1081.7.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.